跳至主要内容
临床试验/CTRI/2024/12/077754
CTRI/2024/12/077754尚未招募2/3 期

A clinical study of the effect of Simhasyadi kwatha in the management of Hyperuricemia.

Dr Aditi Acharya1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年12月17日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
To asses the effectiveness of SIMHASYADI KWATHA in management of symptomatology of Hyperuricemia.

研究概览

简要总结

This is a clinical study of SIMHASYADI KWATHA in management of Hyperuricemia. This study is done as a mandatory Post graduation thesis work. Total number of 60 patients will be studied for 60 days each.

研究设计

研究类型
Interventional
分配方式
Other
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • 1.Patients of both the sex and age between 20-70 years.2.Naive patients or newly diagnosed patients of Hyperuricemia.3.Patients having serum uric acid more than 6.9mg/dl.
  • Patients of Hyperuricemia with Gouty Arthritis.5.Patient recently diagnosed with uncomplicated Hyperuricemia & Gouty Arthritis.6.Hyperuricemic patients suffering from controlled hypertension, diabetes mellitus, CKD upto stage 3.

排除标准

  • 1.Asymptomatic patient with Hyperuricemia.
  • 2.Patients suffering from the complications of Hyperuricemia & Gouty Arthritis.
  • 3.Pregnant and lactating women.
  • 4.Presence of disease like CA, HIV, malignant hypertension, uncontrolled diabetes.
  • Patients suffering from major systemic illness or under long term drug treatment.

结局指标

主要结局

To asses the effectiveness of SIMHASYADI KWATHA in management of symptomatology of Hyperuricemia.

时间窗: 45 days

次要结局

  • To compare the effect of SIMHASYADI KWATHA and FEBUXOSTAT on serum uric acid level parameter.(30, 45 and 60 days)

研究者

发起方
Dr Aditi Acharya
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Aditi Acharya

Govt Ayurvedic College and Hospital Guwahati

研究点 (1)

Loading locations...

相似试验